Bio


Kristin M. Nord, M.D., is a Clinical Professor of Dermatology and served as Residency Program Director from 2012-2022. Dr. Nord received her doctor of medicine from the Columbia University College of Physicians and Surgeons, and completed her residency in Dermatology at New York Presbyterian-Columbia University Medical Center. Dr. Nord is Attending Physician at the VA Palo Alto Health Care System, where her clinical interests are general dermatology, complex medical dermatology and procedural dermatology, and she serves as Assistant Co-Chief of Dermatologic Surgery. Her research focus is on skin cancer education and prevention, and she is co-faculty lead for SUNSPORT (Stanford University Sun Protection Outreach Research and Teamwork).

Academic Appointments


Administrative Appointments


  • Chief, Dermatology Service, James J. Peters Veterans Affairs Medical Center, Bronx, NY (2007 - 2008)
  • Staff Dermatologist, Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA (2008 - Present)
  • Associate Residency Program Director, Department of Dermatology, Stanford University (2010 - 2012)
  • Assistant Chief of Dermatologic Surgery, Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA (2011 - Present)
  • Residency Program Director, Department of Dermatology, Stanford University (2012 - 2022)

Boards, Advisory Committees, Professional Organizations


  • Member, American Medical Women’s Association (1999 - 2003)
  • Member, American Medical Student Association (1999 - 2003)
  • Chapter President, American Medical Student Association (2000 - 2001)
  • Member, Women’s Dermatologic Society (2005 - Present)
  • Member, Society of Dermatology and Dermatologic Surgery (2006 - Present)
  • Member, Skin Cancer Foundation (2006 - Present)
  • Chief resident representative, GME Committee, Columbia University (2006 - 2007)
  • Member, American Academy of Dermatology (2007 - Present)
  • Member, Dermatology Foundation (2007 - Present)
  • Member, National Association of VA Dermatologists (2007 - Present)
  • Member, National VA Dermatology Committee for Digital Photography Initiative (2008 - Present)
  • Member, Same Site Surgery Committee, VA Healthcare system, VISN 21 (2011 - 2011)
  • Member, Surgical Operative and Invasive Procedures Committee, Palo Alto Healthcare System (2011 - Present)
  • Member, San Francisco Dermatological Society (2012 - Present)
  • Member, Association of Professors of Dermatology (2013 - Present)

Professional Education


  • Intern, Department of Internal Medicine, Lenox Hill Hospital, New York, NY (2004)
  • Resident, Department of Dermatology, Columbia University, New York, NY (2007)
  • Chief Resident, Department of Dermatology, Columbia University/New York Presbyterian Hospital, New York, NY (2007)

Community and International Work


  • Faculty member, SUNSPORT (Stanford U Network for Sun Protection Outreach Research & Teamwork)

    Location

    California

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    No

  • Faculty sponsor, Stanford School of Medicine, Dermatology Interest Group

    Location

    Bay Area

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    No

  • Dermatologist Medical Volunteer, Stanford University Skin Cancer Screening

    Ongoing Project

    No

    Opportunities for Student Involvement

    No

  • Dermatologist Medical Volunteer, Women’s Dermatologic Society Skin Cancer Screening

    Location

    Bay Area

    Ongoing Project

    No

    Opportunities for Student Involvement

    No

  • Medical Volunteer, FUNRURAL program, Guatemala City, Guatemala

    Location

    International

    Ongoing Project

    No

    Opportunities for Student Involvement

    No

  • Surgical Operative and Invasive Procedures Committee, Palo Alto Healthcare System

    Location

    Bay Area

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    No

  • Same Site Surgery Committee, VA Healthcare system, VISN 21

    Ongoing Project

    No

    Opportunities for Student Involvement

    No

  • National VA Dermatology Committee for Digital Photography Initiative

    Location

    US

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    No

Clinical Trials


  • Sun Safety Skills for Elementary School Students Not Recruiting

    The overarching goal of this work is to pilot-test a song-based instructional video designed to help elementary school (kindergarten) age children independently apply sunscreen effectively (i.e., covers all needed areas), efficiently (i.e., can be accomplished in 2-3 minutes), consistently (i.e., continues to apply sunscreen routinely before recess both during and after the intervention), without impacting classroom function (i.e., no mess). The video is also designed to encourage use of hats and sunglasses. The outcomes of interest include identification of "gaps" in skills that are consistent for this age group (i.e., commonly miss application to the back of neck), areas of learning refinement (i.e., generalization of skills with different outfits on), and flexibility in terms of adapting practice (i.e., can they do it without the video). The investigators hope that this pilot project will pave the way for broader clinical / educational implementation of this intervention within schools.

    Stanford is currently not accepting patients for this trial. For more information, please contact Julie Weitlauf, PhD, 650-493-5000 Ext. 23429.

    View full details

2024-25 Courses


All Publications


  • Strategies to improve access to photoprotection and sun safety for diverse socioeconomic communities. Archives of dermatological research Gui, H., Jia, J. L., Nord, K. M. 2024; 316 (8): 597

    View details for DOI 10.1007/s00403-024-03309-1

    View details for PubMedID 39251502

  • Clinical outcomes of squamous cell carcinomas following complete saucerization with negative margins: Retrospective case series from 2010-2022. JAAD international Dizon, M. P., Nord, K. M., Swetter, S. M. 2023; 11: 83-84

    View details for DOI 10.1016/j.jdin.2023.01.019

    View details for PubMedID 36941916

    View details for PubMedCentralID PMC10023896

  • Classic ulcerative pyoderma gangrenosum in Fitzpatrick V skin type. Dermatology online journal Gomez, J., Wang, E. A., Nord, K. M. 2022; 28 (3)

    View details for DOI 10.5070/D328357796

    View details for PubMedID 36259817

  • Recurrent bilateral cutaneous squamous cell carcinoma arising within pretibial hypertrophic lichen planus with metastasis while on cemiplimab Journal of the American Academy of Dermatology Case Reports Leeolou, M., Burgren, N., Lee, C., Momeni, A., Pinto, H., Johannet, P., Nord, K., Chang, A. S. 2022
  • The sunscreen for kindergarteners (SKIN) study trial protocol. Contemporary clinical trials Lee, G. H., Bae, G. H., Barnes, L. A., Pol-Rodriguez, M. M., Ransohoff, K. J., Nord, K. M., Lu, Y., Cannell, B., Weitlauf, J. C. 2021: 106480

    Abstract

    BACKGROUND: Exposure to ultraviolet radiation (UVR) is the major modifiable risk factor for skin cancers. The majority of lifetime UVR exposure occurs before age 20, underscoring an important window for risk reduction. Incorporation of skills-based sunscreen education into school health curricula may foster the development of consistent and effective use of sunscreen among children and youth. We describe the study protocol for a first-of-its-kind study that examined the feasibility of bringing skills-based sunscreen education into kindergarten classrooms.METHODS: Participants were 96 kindergarten students across four classrooms in a single elementary school. A single-blind open-label trial design was used to evaluate the feasibility of incorporating a song-based, video-guided intervention for independent application of sunscreen into the kindergarten curriculum. Students first completed a 10-day no-intervention baseline period, followed by a 10-day intervention period, and then a 10-day randomized follow-up period where students were randomly assigned to continue with the intervention or to revert to the no-intervention condition.OUTCOMES: Feasibility metrics associated with study process, resources, management, scientific outcomes and safety were gathered. The primary outcome was pre-to-post intervention changes in student engagement in the sunscreen task. The secondary outcome was pre-to-post intervention changes in the proportion of exposed skin to which a student applies sunscreen. Teacher and student perceptions of intervention value and utility were also evaluated.DISCUSSION: This is the study protocol for a clinical trial designed to determine the feasibility of implementing a skills-based sunscreen curriculum in kindergarten classrooms. Next steps include evaluation of the intervention for efficacy and effectiveness.CLINICAL TRIAL REGISTRATION: NCT03752736.

    View details for DOI 10.1016/j.cct.2021.106480

    View details for PubMedID 34126263

  • An atypical presentation of pretibial myxedema in a euthyroid patient with absent antithyroid autoantibodies. JAAD case reports Beaulieu, D., Nord, K. 2021; 12: 88-90

    View details for DOI 10.1016/j.jdcr.2021.04.018

    View details for PubMedID 34041341

  • Integrating Skin of Color and Sexual and Gender Minority Content in Dermatology Residency Curricula: A Prospective Program Initiative. Journal of the American Academy of Dermatology Jia, J. L., Gordon, J. S., Lester, J. C., Linos, E., Nord, K. M., Bailey, E. E. 2021

    View details for DOI 10.1016/j.jaad.2021.04.018

    View details for PubMedID 33872717

  • Using Visual Arts Education in Dermatology to Benefit Resident Wellness and Clinical Communication. MedEdPORTAL : the journal of teaching and learning resources Kumar, A. M., Lee, G. H., Stevens, L. A., Kwong, B. Y., Nord, K. M., Bailey, E. E. 2021; 17: 11133

    Abstract

    Introduction: Art education interventions improve observation skills among dermatology residents, but there is limited data regarding their benefits to wellness and clinical communication.Methods: Residents in the Stanford dermatology residency program participated in an arts-based education session, repeated in the fall of 2018 and 2019, that included a rotation of observational exercises adapted from the Artful Thinking program through Harvard Project Zero. The 2018 session featured exercises on identification and understanding of visual observation, while the 2019 session featured exercises on perspectives and objectivity of visual observation. Participants completed preintervention, postintervention, and 3-month follow-up surveys in fall 2018 and a postintervention survey in fall 2019.Results: Twenty-one residents participated in the 2018 education session and produced an adequate response rate (62%-90%) across surveys. At 3 months, five of 13 residents (39%) reported new use of art for mindfulness and stress reduction, 12 of 13 (92%) could recall an example of use of observation to improve patient communication, and four of 13 (31%) confirmed and described adjustments to their handoff technique. In 2019, 13 out of 18 participants (72%) completed the postintervention survey. Responses reinforced themes from the prior iteration but focused on perspective, objectivity, context, and uncertainty in observations. Respondents also identified additional arenas of communication to benefit from these observational techniques.Discussion: Dermatology residents increased use of art for personal wellness and adjusted clinical communication strategies after a single arts-based education session. Annual repetition with novel exercises maintained engagement and yielded additional participant insights.

    View details for DOI 10.15766/mep_2374-8265.11133

    View details for PubMedID 33816794

  • Supporting Underrepresented in Medicine (UIM) and non-UIM Trainees Applying into Dermatology: A Qualitative Analysis. Journal of drugs in dermatology : JDD Yu, Z., Jia, J. L., Veerabagu, S. A., Burkemper, N. M., Friedman, A. J., Rosmarin, D., Huang, J. T., Murina, A. T., Nord, K. M. 2021; 20 (7): 795-797

    Abstract

    Recently, there have been calls to improve diversity among the dermatology workforce, with emphasis placed on the resident selection process and trainee pipeline. However, there is limited data on the perspectives of dermatology applicants, especially among UIM trainees, and the support that they need and want to successfully apply in dermatology.To assess trainee perspectives, we disseminated a survey to medical students, interns (matched into dermatology), and dermatology residents asking how dermatology residency programs can best support trainees through the dermatology application process. We developed a codebook drawing upon grounded theory methodology, and consensus coded all qualitative responses.We received 224 qualitative responses from underrepresented in medicine (UIM) (65, 29.0%) and non-UIM trainees (159, 70.9%). UIM trainees were more likely to mention diversity and inclusion initiatives (46.2% vs 3.8%, P<0.001), transparency in program information (40.0% vs 24.5%, P=0.021), holistic review (30.8% vs 6.3%, P<0.001), UIM student outreach/pipeline programs (23.1% vs 0.6%, P<0.001), and mentorship (21.5% vs 8.2%, P=0.009).Improving programmatic efforts to address unique challenges UIM trainees face when applying into dermatology is instrumental to mitigating barriers. We highlight opportunities for dermatology residency programs to create a more fair and equitable dermatology application process and support a more diverse pipeline of future dermatologists. J Drugs Dermatol. 2021;20(7):795-797. doi:10.36849/JDD.6043.

    View details for DOI 10.36849/JDD.6043

    View details for PubMedID 34231995

  • The Association of Professors of Dermatology Program Directors Task Force and Residency Program Transparency Work Group Guidelines on Residency Program Transparency JOURNAL OF DRUGS IN DERMATOLOGY Rosmarin, D., Friedman, A. J., Burkemper, N. M., Nord, K. M., Murina, A. T., Huang, J. T. 2020; 19 (11): 1117–18

    View details for DOI 10.36849/JDD.2020.5600

    View details for Web of Science ID 000593996600017

    View details for PubMedID 33196753

  • Local recurrence of clinically observed basal cell carcinomas following complete saucerization or punch removal with negative margins: retrospective case series from 2010 to 2020. Journal of the American Academy of Dermatology Ransohoff, K. J., Nord, K. M., Bailey, E. E., Ransohoff, J. D., Li, S., Swetter, S. M. 2020

    View details for DOI 10.1016/j.jaad.2020.03.061

    View details for PubMedID 32234307

  • Sexual and Gender Minority Curricula Within US Dermatology Residency Programs. JAMA dermatology Jia, J. L., Nord, K. M., Sarin, K. Y., Linos, E., Bailey, E. E. 2020

    View details for DOI 10.1001/jamadermatol.2020.0113

    View details for PubMedID 32186684

  • Improving Information Transparency Between Dermatology Residency Programs and Trainees: Report from the Association of Professors of Dermatology Work Group on Transparency. Journal of the American Academy of Dermatology Jia, J. L., Yu, Z. n., Veerabagu, S. A., Burkemper, N. M., Friedman, A. J., Rosmarin, D. n., Huang, J. T., Murina, A. T., Nord, K. M. 2020

    View details for DOI 10.1016/j.jaad.2020.08.112

    View details for PubMedID 32891779

  • Promoting sunscreen use and sun-protective practices in NCAA athletes: Impact of SUNSPORT educational intervention for student-athletes, athletic trainers, and coaches JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Ally, M. S., Swetter, S. M., Hirotsu, K. E., Gordon, J., Kim, D., Wysong, A., Donnelly, L., Li, S., Nord, K. M. 2018; 78 (2): 289-+

    Abstract

    Student-athletes (SAs) have an increased skin cancer risk on account of significant ultraviolet exposure; however, their sun-protective practices are suboptimal. A novel program, Stanford University Network for Sun Protection, Outreach, Research, and Teamwork (SUNSPORT), was designed to target SAs, coaches, and athletic trainers (ATs).To measure the impact of educational intervention on sun protection beliefs and practices of SAs.A survey of sun protection beliefs and practices was administered to National Collegiate Athletic Association athletes before and after intervention. SUNSPORT dermatologists educated SAs, coaches, and ATs regarding skin cancer risk and prevention methods. The main outcome was frequency of sunscreen use by SAs before versus after intervention.A total of 846 National Collegiate Athletic Association athletes were surveyed between September 23, 2012, and September 20, 2015. After intervention, significant increases were observed in sunscreen use 4 or more days per week by SAs (from 26% to 39% [P = .02]), SAs spoken to by their coach about sun safety (from 26% to 57% [P = .0001]), and SA recognition of higher skin cancer risk (from 54% to 67% [P = .04]).Intervention in only 1 West Coast university and no paired data.Following the SUNSPORT intervention, SAs were significantly more likely to use sunscreen, especially if encouraged by their coach. This study emphasizes that education directed to SAs, ATs, and coaches can improve sun-protective practices in SAs.

    View details for PubMedID 28993006

  • Standard dermoscopy and videodermoscopy as tools for medical student dermatologic education. Dermatology practical & conceptual Cho, H. G., Sheu, S. L., Chiang, A., Nord, K. M. 2018; 8 (1): 39–42

    View details for PubMedID 29445573

  • Standard dermoscopy and videodermoscopy as tools for medical student dermatologic education DERMATOLOGY PRACTICAL & CONCEPTUAL Cho, H. G., Sheu, S. L., Chiang, A., Nord, K. M. 2018; 8 (1): 39–42
  • Videodermoscopy as a Novel Tool for Dermatologic Education CUTIS Sheu, S. L., Cho, H. G., Nord, K. M. 2017; 100 (2): E25–E27

    Abstract

    Dermoscopy is used as an adjunct to clinical examination in the diagnosis of skin lesions, including melanoma. Videodermoscopy, which allows for the concurrent examination of dermoscopic features at high magnification by instructors and trainees, may serve as a useful educational tool during bedside instruction. This article presents images of common cutaneous lesions taken with a standard optical dermatoscope and a videodermatoscope to highlight the potential educational advantages conferred by videodermoscopy.

    View details for PubMedID 28961304

  • Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis A Randomized Clinical Trial JAMA DERMATOLOGY Pomerantz, H., Hogan, D., Eilers, D., Swetter, S. M., Chen, S. C., Jacob, S. E., Warshaw, E. M., Stricklin, G., Dellavalle, R. P., Sidhu-Malik, N., Konnikov, N., Werth, V. P., Keri, J., Lew, R., Weinstock, M. A. 2015; 151 (9): 952-960

    Abstract

    Topical fluorouracil was demonstrated to be effective in reducing the number of actinic keratoses (AKs) for up to 6 months, but no randomized trials studied its long-term efficacy.To evaluate the long-term efficacy of a single course of fluorouracil cream, 5%, for AK treatment.The Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) trial was a randomized, double-blinded, placebo-controlled trial with patients from dermatology clinics at 12 VA medical centers recruited from 2009 to 2011 and followed up until 2013. Our study population comprised 932 veterans with 2 or more keratinocyte carcinomas in the 5 years prior to enrollment. The mean follow-up duration was 2.6 years in both treatment and control groups.Participants applied either topical fluorouracil cream, 5% (n = 468), or vehicle control cream (n = 464) to the face and ears twice daily for up to 4 weeks.This study reports on AK counts and treatments, which were secondary outcomes of the VAKCC trial. Actinic keratoses on the face and ears were counted by study dermatologists at enrollment and at study visits every 6 months. The number of spot treatments for AKs on the face and ears at semiannual study visits and in between study visits was recorded.The number of AKs on the face and ears per participant was not different between the fluorouracil and control groups at randomization (11.1 vs 10.6, P > .10). After randomization, the fluorouracil group had fewer AKs compared with the control group at 6 months (3.0 vs 8.1, P < .001) and for the overall study duration (P < .001). The fluorouracil group also had higher complete AK clearance rates (38% vs 17% at 6 months) and fewer spot treatments at 6-month intervals, at study visits, and in between study visits during the trial (P < .01 for all). The fluorouracil group took longer to require the first spot AK treatment (6.2 months) compared with the control group (6.0 months) (hazard ratio, 0.69; 95% CI, 0.60-0.79). The number of hypertrophic AKs was not different between the 2 groups overall (P = .60), although there were fewer hypertrophic AKs in the fluorouracil group at 6 months (0.23 vs 0.41) (P = .05).Our results indicate that a single course of fluorouracil cream, 5%, effectively reduces AK counts and the need for spot treatments for longer than 2 years.clinicaltrials.gov Identifier:NCT00847912.

    View details for DOI 10.1001/jamadermatol.2015.0502

    View details for PubMedID 25950503

  • Mycophenolate mofetil-induced oral ulcerations in solid organ transplant recipients: A report of 3 cases. JAAD case reports Salik, J., Tang, R., Nord, K., Schneiderman, P. I., Grossman, M. E. 2015; 1 (5): 261-263

    View details for DOI 10.1016/j.jdcr.2015.06.005

    View details for PubMedID 27051747

    View details for PubMedCentralID PMC4809219

  • Chromhidrosis: a rare diagnosis requiring clinicopathologic correlation. American Journal of dermatopathology Wang, A., Wysong, A., Nord, K. M., Egbert, B. M., Kosek, J. 2014; 36 (10): 853-855

    Abstract

    : Chromhidrosis is a rare idiopathic disorder characterized by colored secretions most typically from the malar cheeks, axilla, or areolar regions. Histologically, chromhidrosis is notable for glandular structures with decapitation secretion indicating ectopic apocrine glands in the dermis, and the presence of lipofuscin pigments under ultraviolet fluorescence and in cytology smears. This case report describes a 26-year-old man who presented with a 2- to 3-year history of black-colored secretions on the bilateral malar cheeks, present on exertion or with squeezing of the cheeks. A 3-mm punch biopsy of the left cheek demonstrated histopathologic findings characteristic of chromhidrosis under hematoxylin and eosin staining and ultraviolet fluorescence. To our best knowledge, this is the second case report in the literature of an adult male being affected by chromhidrosis, and the first of an adult male with black-colored malar cheek secretions in chromhidrosis.

    View details for DOI 10.1097/DAD.0b013e3182871a17

    View details for PubMedID 23503318

  • Chromhidrosis: A Rare Diagnosis Requiring Clinicopathologic Correlation AMERICAN JOURNAL OF DERMATOPATHOLOGY Wang, A., Wysong, A., Nord, K. M., Egbert, B. M., Kosek, J. 2014; 36 (10): 853-855

    Abstract

    : Chromhidrosis is a rare idiopathic disorder characterized by colored secretions most typically from the malar cheeks, axilla, or areolar regions. Histologically, chromhidrosis is notable for glandular structures with decapitation secretion indicating ectopic apocrine glands in the dermis, and the presence of lipofuscin pigments under ultraviolet fluorescence and in cytology smears. This case report describes a 26-year-old man who presented with a 2- to 3-year history of black-colored secretions on the bilateral malar cheeks, present on exertion or with squeezing of the cheeks. A 3-mm punch biopsy of the left cheek demonstrated histopathologic findings characteristic of chromhidrosis under hematoxylin and eosin staining and ultraviolet fluorescence. To our best knowledge, this is the second case report in the literature of an adult male being affected by chromhidrosis, and the first of an adult male with black-colored malar cheek secretions in chromhidrosis.

    View details for Web of Science ID 000344119600018

  • Pedunculated scrotal nodule in an elderly male: a rare presentation of trichoblastoma. Cutis Navi, D., Egbert, B., Nord, K. M. 2014; 94 (2): E8-9

    View details for PubMedID 25184656

  • Pyoderma Gangrenosum-like Lesions in Leukocyte Adhesion Deficiency I Treated with Intravenous Immunoglobulin PEDIATRIC DERMATOLOGY Nord, K. M., Pappert, A. S., Grossman, M. E. 2011; 28 (2): 156-161

    Abstract

    A 31-year-old Caucasian male with leukocyte adhesion deficiency I and a 20-year history of recurrent, painful cutaneous ulcerations on the extremities presented with fatigue and worsening pain in both legs. He had experienced minimal improvement in his leg ulcers from treatment with systemic steroids, numerous courses of systemic antibiotics, and brief trials of infliximab and mycophenolate mofetil. He was treated with monthly intravenous immunoglobulin infusions. Upon completion of six courses of intravenous immunoglobulin his ulcerations had nearly healed for the first time in a decade.

    View details for DOI 10.1111/j.1525-1470.2010.01123.x

    View details for Web of Science ID 000290381900013

    View details for PubMedID 21366684

  • Acquired epidermodysplasia verruciformis JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Rogers, H. D., MacGregor, J. L., Nord, K. M., Tyring, S., Rady, P., Engler, D. E., Grossman, M. E. 2009; 60 (2): 315-320

    Abstract

    Epidermodysplasia verruciformis (EV) is a rare autosomal recessive genodermatosis with an increased susceptibility to specific human papillomavirus (HPV) genotypes. Classically, this viral infection leads to the development of tinea versicolor-like macules on the trunk, neck, arms, and face during childhood, and over time, these lesions can progress to squamous cell carcinoma. More recently, an EV-like syndrome has been described in patients with impaired cell-mediated immunity. We describe two cases of EV-like syndrome in HIV-positive patients, review all previously reported cases of EV in patients with impaired cell-mediated immunity, introduce the term "acquired epidermodysplasia verruciformis" to describe EV developing in the immunocompromised host and examine the limited treatment options for these patients.

    View details for DOI 10.1016/j.jaad.2008.08.035

    View details for Web of Science ID 000262617700019

    View details for PubMedID 19150275

  • Glomus tumor masquerading for 22 years as osteoarthritis of the hip CUTIS Weiser, J. A., Nord, K. M., Grossman, M. E. 2008; 81 (4): 339-342

    Abstract

    Glomus tumors are rare benign mesenchymal neoplasms that account for less than 2% of soft tissue tumors. These neoplasms typically are small nodules less than 1 cm in diameter, associated with pain that is exacerbated by tactile stimulation and cold hypersensitivity. We present a case of a large glomus tumor of the left lateral hip associated with a long history of severe pain of the left hip interfering with ambulation. Chronic pain as a result of a subcutaneous glomus tumor is rare and frequently misdiagnosed. In the case reported, a solid glomus tumor presented with 22 years of unilateral hip pain attributed to posttraumatic degenerative joint disease. Excision of a 4 x 3-cm nodule resulted in complete resolution of tenderness and joint pain. Subcutaneous glomus tumors can have unusually large size and location and should be considered in the differential diagnosis of chronic, atypical, or treatment-resistant joint pain.

    View details for Web of Science ID 000255232700008

    View details for PubMedID 18491482

  • Soft papules and nodules on the buttock. Archives of dermatology Pol-Rodriguez, M. M., Nord, K. M., Engler, D. E. 2007; 143 (12): 1583-1588

    View details for PubMedID 18087013

  • Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: Case report and review of the literature (vol 118, pg e907, 2007) PEDIATRICS Nord, K. M., Kandel, J., Lefkowitch, J. H. 2007; 119 (6): 1271-1271
  • Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment BRITISH JOURNAL OF DERMATOLOGY Goss, J. M., Nord, K. M., Olarte, M. R., Grossman, M. E. 2007; 156 (3): 582-582
  • Repair of a conchal bowl defect extending through the conchal cartilage DERMATOLOGIC SURGERY Magnuson, K. A., Ratner, D. 2002; 28 (12): 1165-1167

    View details for Web of Science ID 000179751300014

    View details for PubMedID 12472499